The "Respiratory Care Devices - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The ...

GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its ...

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

Apple and Beats on Tuesday unveiled the much-anticipated Powerbeats Pro 2 wireless earbuds. Surprisingly, the new version of ...

Although these factors will affect Omron's free cash flow generation in fiscal 2024, we expect this to be temporary and the company's financial health to return to its normal state over the medium ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Mike White’s first job as a television writer, in the late nineties, was on the teen soap opera “Dawson’s Creek.” It was a ...

Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients ...

Lindsey Vonn’s opening race at the Alpine skiing world championships lasted all of 25 seconds. The American got caught on the ...

AI agents, power struggles, and more apps from third-party developers: Here’s what’s coming in 2025 and beyond ...

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...